A recent study published in PubMed highlights the extended follow-up of CD19 CAR T-cell therapy in patients with connective tissue disease-associated pulmonary arterial hypertension. This research contributes to understanding the potential of CAR T-cell therapy in rare diseases.
extended follow up of cd19 car t cell therapy in connective tissue disease associated pulmonary arterial hypertension
Original title: “Extended follow-up of CD19 CAR T-cell therapy in connective tissue disease-associated pulmonary arterial hypertension.”